Stock Taper 
PASG
$4.65
▼ DOWN 2.11% (-0.10)
KEY STATISTICS
Market Cap$15.15 M
52w High$20.00
52w Low$3.29
Dividend Yield—
Frequency—
P/E-0.39
Volume3.61K
Shares Out.3.21M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
William Chou
COMPENSATION 2026
Salary$660,985
Stock Awards$234,040
Incentive Plan Pay$334,972
All Other Comp.$17,500
Total$1,486,763
ABOUT
SECTOR
Healthcare
WENT PUBLIC
February 28, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
24
PRICE TARGET
Target High$15.00
Target Low$7.00
Target Median$8.00
Target Consensus$10.00
UPCOMING EARNINGS
DateNov 9, 2026
DayMonday
Rev. Est.—
NOV
9
MON
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2025-07-14 | Reverse | 1:20 |
PRICE
$4.65 ▼ DOWN 2.11% (−$0.10)About Passage Bio, Inc.
https://www.passagebio.com ↗Passage Bio, Inc. develops gene therapies for CNS diseases using AAV vectors, targeting conditions like GM1, FTD-GRN, Krabbe, and others, through collaborations with university and industry partners.
INDUSTRY
Biotechnology
A PRODUCT PASSAGE BIO, INC. IS KNOWN FOR
PBFT02
PBFT02 is a Passage Bio AAV gene therapy in Phase 1/2 trials for FTD with GRN mutations, aiming to restore progranulin levels and slow disease progression with a one-time treatment.
ETFS HOLDING THIS STOCK
ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
100.00%
HOLDERS
51
TOP 12 OF 51 · RANKED BY POSITION SIZE
Highline Capital Management, L.P.
Blackrock Inc.
Lynx1 Capital Management LP
Vestal Point Capital, LP
Weiss Multi-Strategy Advisers LLC
Renaissance Technologies LLC
Eversept Partners, LP
Indexiq Advisors LLC
Vanguard Group Inc
Erste Asset Management Gmbh
New Leaf Venture Partners, L.L.C.
Yiheng Capital Management, L.P.
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score2
INSIDER TRADES
★
10 PERCENT OWNER
Lynx1 Capital Management LP
Purchase · 50.1K shares
2026-06-25
★
DIRECTOR
Sondhi Dolan
Purchase · 10.5K shares
2026-05-19
★
DIRECTOR
Porter Derrell
Purchase · 10.5K shares
2026-05-19
★
DIRECTOR
Kassberg Thomas Richard
Purchase · 10.5K shares
2026-05-19
MOST RECENT ANALYST GRADES
GRADE SUMMARY
NEUTRAL 2
OUTPERFORM 1
HOLD 1
BUY 1
5 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 CING | $5.11 | COMPARE |
 ALLR | $1.43 | COMPARE |
 ENLV | $1.11 | COMPARE |
 LSTA | $1.69 | COMPARE |
 GDTC | $0.88 | COMPARE |
 NCNA | $1.41 | COMPARE |
 XCUR | $1.25 | COMPARE |
 CLGN | $3.75 | COMPARE |